ConductScience.org, home

Paper40417828

rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli.

Jia Q and 3 others. Hum Vaccin Immunother, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli. Papers, record 40417828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40417828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli.
PubMed
Journal
Hum Vaccin Immunother
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-02
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jia QQingmeihttps://orcid.org/0000-0002-2328-4806
2Bowen RARichard Ahttps://orcid.org/0000-0002-7576-2881
3Masleša-Galić SSaša
4Horwitz MAMarcus Ahttps://orcid.org/0000-0001-6525-7147

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PlagueMajor topic
Plague VaccineMajor topic
Pore Forming Cytotoxic ProteinsMajor topic
Yersinia pestisMajor topic
Antigens, BacterialMajor topic
Bacterial ProteinsMajor topic
Fimbriae ProteinsMajor topic
Animals
Vaccines, Attenuated
Female
Antibodies, Bacterial
Vaccines, Synthetic
Mice
Mice, Inbred BALB C
Disease Models, Animal
Immunization, Secondary
Genetic Vectors
Survival Analysis
Francisella tularensis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI141390NIAID NIH HHSUnited StatesR01AI141390PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115574954Construction and characterization of a highly efficient Francisella shuttle plasmid.Appl Environ Microbiol2004https://conductscience.org/library/papers/15574954PubMed
227722869Plague Vaccines: Status and Future.Adv Exp Med Biol2016https://conductscience.org/library/papers/27722869PubMed
333514747A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform.NPJ Vaccines2021https://conductscience.org/library/papers/33514747PubMed
439242587Progress on the research and development of plague vaccines with a call to action.NPJ Vaccines2024https://conductscience.org/library/papers/39242587PubMed
527170642A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Clin Vaccine Immunol2016https://conductscience.org/library/papers/27170642PubMed
68578841A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model.Vaccine1995https://conductscience.org/library/papers/8578841PubMed
78890210Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.Infect Immun1996https://conductscience.org/library/papers/8890210PubMed
829725025Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.Sci Rep2018https://conductscience.org/library/papers/29725025PubMed
98675324Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.Infect Immun1996https://conductscience.org/library/papers/8675324PubMed
1015978133Immunization of mice with YscF provides protection from Yersinia pestis infections.BMC Microbiol2005https://conductscience.org/library/papers/15978133PubMed
1121763383Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.Vaccine2011https://conductscience.org/library/papers/21763383PubMed
1218347051Yersinia pestis caf1 variants and the limits of plague vaccine protection.Infect Immun2008https://conductscience.org/library/papers/18347051PubMed
1321193666Identification and characterization of novel and potent transcription promoters of Francisella tularensis.Appl Environ Microbiol2011https://conductscience.org/library/papers/21193666PubMed
1423439306
A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
Infect Immun2013https://conductscience.org/library/papers/23439306PubMed
1537975637The rLVS ΔcapB/iglABC vaccine provides potent protection in Fischer rats against inhalational tularemia caused by various virulent Francisella tularensis strains.Hum Vaccin Immunother2023https://conductscience.org/library/papers/37975637PubMed
169281474Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.Microb Pathog1997https://conductscience.org/library/papers/9281474PubMed
1716987180Type IV pili-mediated secretion modulates Francisella virulence.Mol Microbiol2006https://conductscience.org/library/papers/16987180PubMed
1823853602Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines.PLoS Pathog2013https://conductscience.org/library/papers/23853602PubMed
1936916971Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters.Microbiol Spectr2023https://conductscience.org/library/papers/36916971PubMed
208745007A new improved sub-unit vaccine for plague: the basis of protection.FEMS Immunol Med Microbiol1995https://conductscience.org/library/papers/8745007PubMed

See all 31 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42964573Multi-pathogen and combination vaccines for biodefense pathogens.Front Immunol2026https://conductscience.org/library/papers/42964573PubMed
42576894Anti-infective compounds for Yersinia.Sustain Microbiol2026https://conductscience.org/library/papers/42576894PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40417828

GET https://conductscience.org/api/papers/v1/40417828/references?page=2